OVERVIEW

4th Biologics & Biosimilars Congress is organized by Global Engage Ltd and will be held during Mar 05 - 06, 2018 at Berlin, Germany.

Course Description:
This conference will provide in-depth studies of antibody therapeutics, biotherapeutic development and biologics for immunotherapy, including oncology and treatment of autoimmune disease and an expanded session on Antibody-Drug Conjugates, as well as a session examining recent clinical and regulatory developments in biosimilars. With over 60 presenters expected to attend and several planned panel discussions on topics including the impact of bispecific antibodies on oncology, developing antibody therapeutics, reviewing antibody-drug conjugate progress, and the current market landscape for biosimilars, this interactive meeting will provide the opportunity to take home cutting-edge research, strategies and case study examples and to forge connections with other experts in this field.

Additional details will be posted as soon as they are available.